Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNN4 | O15554 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | AKT1 | P31749 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | ESRRB | O95718 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MITF | O75030 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14002768 | 0.84 | CYP2C19 (0.53) | KCNN4LMNAALDH1A1KDM4EAKT1 | |
| SCHEMBL6341499 | 0.83 | KCNN4 (0.44) | KCNN4LMNAALDH1A1KDM4EAKT1 | |
| SCHEMBL2008935 | 0.83 | SMN1; SMN2 (0.55) | LMNAALDH1A1KMT2AHSD17B10POLB | |
| SCHEMBL19766890 | 0.82 | SMN1; SMN2 (0.47) | KCNN4LMNAALDH1A1KDM4EAKT1 | |
| SCHEMBL8698880 | 0.82 | ALDH1A1 (0.50) | KCNN4LMNAALDH1A1KDM4EAKT1 | |
| SCHEMBL4679670 | 0.82 | CNR1 (0.52) | KCNN4LMNAALDH1A1KDM4EAKT1 | |
| SCHEMBL27447004 | 0.80 | KCNN4 (0.50) | KCNN4LMNAALDH1A1KDM4EAKT1 | |
| SCHEMBL13232139 | 0.79 | ALDH1A1 (0.48) | KCNN4LMNAALDH1A1MAPTKMT2A | |
| SCHEMBL24451337 | 0.79 | KCNN4 (0.49) | KCNN4LMNAALDH1A1KDM4EAKT1 | |
| Trifluoromethylbenzene SCHEMBL27846765 | 0.79 | L3MBTL1 (0.47) | KCNN4LMNAALDH1A1KDM4EAKT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230099421-A1 | A NEW METHOD OF 18F LABELLING AND INTERMEDIATE SALTS | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2023-03-30 | — | — | US | disclosed |
| EP-3925945-A1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | Daikin Industries, Ltd. (JP) | 2021-12-22 | — | — | EP | disclosed |
| EP-3428145-B1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | DAIKIN IND LTD (JP) | 2021-09-08 | — | — | EP | disclosed |
| US-20190071376-A1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2019-03-07 | — | — | US | disclosed |
| EP-3428145-A1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | Daikin Industries, Ltd. (JP) | 2019-01-16 | — | — | EP | disclosed |
| US-8143425-B2 | Heterocyclic aromatic compounds useful as growth hormone secretagogues | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| US-8143425-B2 | Heterocyclic aromatic compounds useful as growth hormone secretagogues | BRISTOL-MYERS SQUIBB COMPANY (US) | 2012-03-27 | — | — | US | disclosed |
| WO-2007111994-A2 | COMPOUNDS AND METHODS FOR TREATMENT OF DISORDERS ASSOCIATED WITH ER STRESS | SYNDEXA PHARMACEUTICALS CORPORATION (US) | 2007-10-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230099421-A1 | A NEW METHOD OF 18F LABELLING AND INTERMEDIATE SALTS | NPY1R, TMEM14C, SLCO1B1 | KCNN4 403/4885LMNA 2971/4885ALDH1A1 1086/4885 |
| US-20190071376-A1 | METHOD FOR PRODUCING FLUORINATED COMPOUND | RXFP2, BLVRB, AFF2 | KCNN4 3708/4885LMNA 2267/4885ALDH1A1 1416/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.